Birchbrook’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35M Buy
4,505
+28
+0.6% +$15.3K 1.13% 19
2026
Q2
$2.36M Sell
4,477
-37
-0.8% -$20.8K 1.11% 18
2026
Q1
$2.54M Sell
4,514
-115
-2% -$73.7K 1.24% 18
2025
Q4
$3.13M Sell
4,629
-89
-2% -$60.6K 1.56% 15
2025
Q3
$3.01M Sell
4,718
-30
-0.6% -$18.2K 1.56% 13
2025
Q2
$2.55M Sell
4,748
-1,145
-19% -$548K 1.36% 15
2025
Q1
$2.47M Buy
5,893
+48
+0.8% +$20.8K 1.39% 14
2024
Q4
$2.42M Buy
5,845
+88
+2% +$38.6K 1.37% 16
2024
Q3
$2.91M Buy
5,757
+214
+4% +$104K 1.61% 12
2024
Q2
$2.7M Sell
5,543
-37
-0.7% -$18.6K 1.62% 12
2024
Q1
$3.01M Sell
5,580
-284
-5% -$155K 1.79% 10
2023
Q4
$3.25M Buy
+5,864
New +$2.75M 2.15% 9

Other funds holding IDXX

Birchbrook's IDXX Position: Q3 2026 in Review

Birchbrook increased its Idexx Laboratories (IDXX) stake by 0.63% in Q3 2026, buying an estimated $15.3K and bringing the position to 4,505 shares worth $2.35M. The position accounts for 1.13% of the portfolio, ranked #19.

Birchbrook first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.25M in Q4 2023. 460 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Birchbrook held 4,505 shares of Idexx Laboratories worth $2.35M as of Q3 2026.
  • Birchbrook bought 28 Idexx Laboratories shares in Q3 2026, an estimated $15.3K.
  • Idexx Laboratories made up 1.13% of Birchbrook's portfolio in Q3 2026, its #19 holding.
  • Birchbrook first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
  • Birchbrook's Idexx Laboratories position peaked at $3.25M in Q4 2023.
  • 460 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.